Literature DB >> 5662871

Inhibition by H-1 virus of the incidence of tumors produced by adenovirus 12 in hamsters.

H W Toolan, N Ledinko.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5662871     DOI： 10.1016/0042-6822(68)90226-2

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  16 in total

Review 1.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

2.  Selective killing of transformed rat cells by minute virus of mice does not require infectious virus production.

Authors:  E Guetta; M Mincberg; S Mousset; C Bertinchamps; J Rommelaere; J Tal
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Studies on inhibition of viral oncogenesis. 3. Effect of clam extracts and methotrexate on tumor formation in male and female hamsters induced by virulent and attenuated adenovirus-12.

Authors:  C P Li; N M Tauraso; B Eddy; B Prescott; E C Martino
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.

Authors:  Iván Ventoso; Juan J Berlanga; José M Almendral
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

5.  Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells.

Authors:  M P Rubio; S Guerra; J M Almendral
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Bioavailability, biodistribution, and CNS toxicity of clinical-grade parvovirus H1 after intravenous and intracerebral injection in rats.

Authors:  Karsten Geletneky; Anne-Laure Leoni; Gabriele Pohlmeyer-Esch; Stephanie Loebhard; Barbara Leuchs; Constance Hoefer; Karin Jochims; Michael Dahm; Bernard Huber; Jean Rommelaere; Ottheinz Krebs; Jacek Hajda
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

7.  Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical-grade parvovirus H1.

Authors:  Karsten Geletneky; Anne-Laure Leoni; Gabriele Pohlmeyer-Esch; Stephanie Loebhard; Andrea Baetz; Barbara Leuchs; Mandy Roscher; Constance Hoefer; Karin Jochims; Michael Dahm; Bernard Huber; Jean Rommelaere; Ottheinz Krebs; Jacek Hajda
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

8.  Translationally controlled tumor protein is a target of tumor reversion.

Authors:  Marcel Tuynder; Giusy Fiucci; Sylvie Prieur; Alexandra Lespagnol; Anne Géant; Séverine Beaucourt; Dominique Duflaut; Stéphanie Besse; Laurent Susini; Jean Cavarelli; Dino Moras; Robert Amson; Adam Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

9.  Formation of a host range mutant of the lymphotropic strain of minute virus of mice during persistent infection in mouse L cells.

Authors:  D Ron; P Tattersall; J Tal
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Transformation of human cells by oncogenic viruses supports permissiveness for parvovirus H-1 propagation.

Authors:  S Faisst; J R Schlehofer; H zur Hausen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.